Pruebas Especializadas

Catálogo de Análisis y Pruebas de Laboratorio

Nuestro catálogo de análisis y pruebas está basado en una gran alianza con los mejores laboratorios en Estados Unidos de America, Canada y Europa por lo que ofrecemos la mejor calidad y confiabilidad en nuestros procedimientos y resultados.
Al final de esta página encontrará información de nuestros laboratorios aliados, para ver la totalidad de estudios que podemos ofertar solo dé un click en la imagen del laboratorio de su interés:

Mamario

  • ER / PR / Ki-67 / DNA / HER2 – Reflex to HER2 by FISH
  • ER / PR / Ki-67 / HER2 – Reflex to HER2 by FISH
  • ER / PR / HER2 – Reflex to HER2 by FISH
  • HER2 by IHC reflex to HER2 by FISH
  • HER2 by IHC
  • HER2 by FISH
  • ER/PR by IHC
  • Ki67 by IHC
  • P53 by IHC
  • Breast Carcinoma Lymph Nodes / MM Metastasis by IHC
  • Breast Carcinoma Rule Out Microinvasion by IHC
  • Breast Carcinoma Bone Marrow Micrometastasis by IHC

Cervical

  • GenCerv (VPH E6/E7 mRNA Expression)

Pulmón

  • Lung Profile: KRAS + EGFR by PCR, ELM4-ALK and ROS1 by FISH
  • Lung Total Panel (KRAS, EGFR, and ERCC1 by PCR and EML4/ALK by FISH)
  • Lung Adeno Reflex Dx: EGFR + KRAS by PCR if Neg. Rfx. to ALK if Neg. Rfx. to ROS1 by FISH)
  • Lung Adeno Reflex Panel (EGFR if Neg. Reflex to KRAS if Neg. reflex to EML4/ALK by FISH)
  • EGFR gene analysis by PCR
  • EGFR by PCR if Negative Reflex to EML4/ALK by FISH
  • Lung Adenocarcinoma vs. Squamous Cell Carcinoma
  • Adenocarcinoma vs. Mesothelioma Panel by IHC
  • KRAS by PCR if Neg. Reflex to BRAF
  • BRAF V600E Mutation Analysis by PCR
  • ALK (EML4/ALK) by FISH
  • ALK (EML4/ALK) by IHC
  • ROS1 by FISH
  • ERCC1 by RT-PCR
  • c-MET by IHC

Colon

  • Colon Total Reflex Panel by PCR (KRAS Reflex to BRAF and MSI to MLH1
  • Colon DNA Mismatch Repair by PCR (MSI) If Positive Reflex to MLH1
  • Colon Reflex Dx. (KRAS + MSI by PCR if Positive Reflex to BRAF and MLH1)
  • KRAS by PCR Reflex to BRAF
  • P53 by IHC
  • Metastatic Carcinoma – Lymph Node (AE1/AE3)
  • UGT1A1 Mutation Analysis by PCR
  • Microsatellite Instability (MSI) by PCR
  • Mismatch Repair Protein (MMR) for Lynch Sx. by IHC
  • MLH1 Promoter Hypermethylation by PCR
  • MLH1 by IHC
  • MSH2 by IHC
  • MSH6 by IHC

Gástrico / Esofagogástrico

  • GIST (GastroIntestinal Stromal Tumors) Profile by IHC
  • MALToma (API2-MLT, t(11;18)
  • c-KIT/PDGFRA for GIST by PCR

Linfomas

  • Non-Hodgkins (BCL1, BCL2, BCL6) Panel by FISH
  • B Cell (IGH) by PCR and by FISH
  • Burkitt (MYC/IGH), t(8;14) by FISH
  • Difuse Large B Cell (BCL6, 3q27) by FISH
  • Follicular (IGH, BCL2), t(14;18) by PCR and by FISH
  • Mantle Cell (BCL1/IGH), t(11;14) by FISH
  • T-Cell (IGH/TCR Gamma) by PCR – Hodgkin Lymphoma (NHL vs. Classical) Panel by IHC
  • Carcinoma vs. Lymphoma Panel by IHC
  • Reactive Hyperplasia vs. Lymphoma (NHL) Panel by IHC

Piel

  • c-KIT for Mastocytocis (D816V, D816Y, D816F) by PCR
  • BRAF V600E Mutation Analysis by PCR
  • Metastatic Melanoma – Lymph Node(AE1/AE3)
  • Spindle Cell Neoplasm Panel by IHC

Médula Ósea

  • Multiple Myeloma Panel (RB1, BCL1, p53, FGFR3) by FISH
  • Plasma Cell Dyscrasia/Multiple Myeloma Panel by IHC
  • Immunofixation, Serum (M- Spike Mieloma Múltiple)
  • Bone Marrow Analysis – Clot Only
  • Bone Marrow Analysis – Core Only
  • Bone Marrow Analysis – Smear Only
  • Bone Marrow Comprehensive Morphology (Clot, Core, Smear)
  • Bone Marrow Smear Interpretation
  • Bone Marrow Transplant Monitoring (X/Y) by FISH

Leucemias

Agudas

  • ALL (B-ALL) Prognostic Panel (t(9;22), 11q23)by FISH
  • AML Diagnostic Panel t(9;22), 11q23, t(8;21), t(15;17), inv (16) by FISH
  • AML Treatment Related Panel (+8, -5q, -7q, 20q12) by FISH
  • AML – M1, Others t(9;22) BCR/ABL by PCR and by FISH
  • AML – M2 (AML/ETO) t(8;21) by FISH and by PCR (RUNX1/RUNX1T1)
  • AML – M3 (PML/RARA) t(15;17) by RT-PCR and by FISH
  • AML – M4 Eo (inv16) by PCR and by FISH
  • AML – M4 /M5 (MLL) 11q23, t(4;11) by FISH
  • AML Prognostic Panel (FLT3/NPM1 Mutation Analysis) by PCR
  • AML Prognostic CEBPA Mutation Analysis by PCR
  • AML – NMP1 Mutation Analysis by PCR
  • Acute Leukemia / Myeloid Disorders Panel by IHC
  • FLT3 Mutation Analysis by PCR
  • TEL/AML1 t(12;21)by FISH
  • ETV6/RUNX1 t(12;21) by PCR
  • MLL 11q23 by FISH

Crónicas:

  • Chronic Eosinofilic Leukemia (FIP1L1-PDGFRA) by FISH
  • CLL Panel (+12, 13q14.3, 17p13, 11q22) by FISH
  • CLL Prognosis by IgVH Mutation Analysis by PCR
  • CML – BCR/ABL t(9;22) by RT PCR and by FISH
  • CML – ABL Kinase Mutation Analysis by PCR
  • PDGFR beta/ TEL by FISH for CMML

Mieloproliferativos

  • MDS Panel by FISH
  • JAK2 V617F Mutation Analysis for PV, ET, CIMF
  • MPL 515 Mutation Analysis (Only if JAK2 V617F is Negative) for ET, CIMF
  • JAK Exon 12 Mutation Analysis (Only if JAK V617F is Negative) for PV

Farmacogenómica e Individualizada

  • Circulating Tumor Cells (Breast, Colon, Prostate Prognosis) by Indirect Fluorescence Assay
  • Imatinib Resistance in CML(ABL Kinase) by PCR
  • Irinotecan Toxicity (UGT1A1 by PCR
  • Tamoxifen Efficacy (CYP2D6) by PCR
  • DPD-5 FU Genotype for Drug Toxicities by PCR
  • Plavix Efficacy (CYP2C19) by PCR
  • Warfarin (Coumadin) Sensitivity (VKORC1)
  • MTHFR A1298C Mutation Analysis by PCR
  • MTHFR C677T Gene Mutation by PCR
  • PGT Guía Personalizada para Medicamentos 

Citometría de Flujo

  • Acute Leukemia / Myeloid Disorders Analysis
  • Myeloid and Lmyphoid Short Panel
  • Plasma Cell Analysis
  • Lymphoproliferative Disorders Analysis
  • ZAP-70 CLL/SLL Prognosis Panel
  • Minimal Residual Disease Analysis for CLL/SLL
  • DNA Ploidy/S-Phase for Breast CA Prognosis
  • HLA-B27 (Espondilitis Anquilosante)

Próstata

  • Prostate Carcinoma Panel (CK903, p63, P504S) by IHC
  • Prostate Carcinoma Lymph Node for Metastasis
  • CK-903 by IHC

Urinario

  • Comprehensive Urine Pathology (UroVysion + Urine Cytopathology) by FISH
  • Automated UroVysion by FISH
  • Urine Cytopathology (Global)

Hígado

  • Hepatocellular vs. Cholangiocarcinoma vs. Metastasis Panel by IHC
  • Hereditary Hemochromatosis (C282Y, H63D, S65C) by PCR

Cromosómicos y Variados

  • Tumor of Unknown Primary Panel by IHC
  • Neuroendocrine Neoplasm Panel by IHC
  • Germ Cell Tumors Panel by IHC
  • p53 by FISH
  • 1p/19q Deletion for Oligodendrogliomas by FISH
  • DNA + S-Phase Analysis (Hydatidiform Mole Assesment)
  • Aneuploidy 13, 18, 21, X, Y by FISH
  • Chromosome Analysis, Peripheral Blood
  • Chromosome Analysis, Products of Conception
  • Chromosome Analysis, Amniotic Fluid
  • Pathology Peripheral Smear Review
  • Pathology Slide Consultation

Pruebas Genéticas

  • HerediT Cystic Fibrosis Carrier Screen
  • Expanded Cystic Fibrosis
  • GenArray Molecular Karyotyping (aCGH) by Cytogenetics
  • Chromosome Analysis by Cytogenetics 
  • InherigenTx Genetic panel
  • Inherigen Plus Genetic Panel

Pruebas Prenatales No-Invasivas

  • MaterniT Genome (Cariotipo Genómico Completo)
  • MaterniT21 Plus (Panel Genético Completo incluye Microdeleciones)
  • MaterniT21 Básico (T21, 18, 13 y Género Fetal)
  • VisibiliT (Riesgo para T18 y 21 y Género Fetal)
  • Preeclampsia Test (11-14 semanas de embarazo)
  • SensiGene Genotipificación Fetal de RhD
  • Género Fetal

Pruebas de Paternidad No-Invasivas

  • Examen de Paternidad No-Invasivo a partir de las 14 semanas
    (Incluye 2 muestras paternas en saliva o forénsicas)
  • Examen de Paternidad Postnatal

Paneles Cardio-Metabólicos

  • Comprehensive Heart Health Baseline (ACT 1)
  • Heart Health Baseline (ACT 2)
  • Comprehensive Heart Health Monitoring (ACT 3)
  • Heart Health Monitoring (ACT 4)

Salud de la Mujer

  • Hereditaria 22 Panel de 22 genes para Cáncer Hereditario (Incluye BRCA 1 y 2)
  • OAR (Índice de Reserva Ovárica)
  • Panel de Anticuerpos Antifosfolípido para Pérdidas Recurrentes
  • OVA 1 (Marcador Integral Individualizado para el Riesgo de Cáncer de Ovario)

Imunoalergología

  • Respiratory Allergy Profile
  • Chilhood Allergy Profile
  • Food Allergy Profile

Paneles Oncogénicos Especializados

  • OncogeneDx BRCA 1 and 2 Gene Sequencing
  • OncogeneDx BRCA 1 and 2 Deletions/Duplication
  • OncogeneDx BRCA 1 and 2 Gene Sequencing/Del/Dup
  • Breast and Ovarian Extended Panel (21 Genes)
  • High Risk Breast Cancer Panel (6 Genes)
  • Lynch Colorectal Cancer Panel (7 Genes)
  • Colorectal Cancer Panel (16 Genes)
  • Endometrial Cancer Panel (11 Genes)
  • Pancreatic Cancer Panel (19 Genes)
  • Panel Exhaustivo Integral (29 Genes)
  • Peutz-Jeghers Syndrome Deletion/Duplication Analysis
  • Peutz-Jeghers Syndrome Sequencing/Del/Dup

* Cualquier tipo de enfermedad o síndrome hereditario por raro que éste sea, son la especialidad de la casa.

Tamiz Neonatal Extendido

  • Baby Genes por Next Generation Sequencing (92 genes y 71 condiciones Metabólicas)

Next Generation Sequencing

  • Screening de Portador (92 genes y 71 condiciones Metabólicas)
  • Lung NGS Panel
  • Melanoma NGS Panel
  • Colon NGS Panel
  • Solid Tumor NGS Panel
  • OnkoSight Lung Cancer Panel + ALK, if Neg. reflex to ROS1
  • Myeloid Disorders NGS Panel
  • Myelodysplastic Sx. NGS Panel
  • Myelopoliferative Neoplasms NGS Panel
  • AML NGS Panel
  • KRAS by NGS
  • NRAS by NGS
  • EFGR by NGS
  • KIT by NGS
  • BRAF by NGS

PCR: Polymerase Chain Reaction
FISH: Fluorescence In Situ Hybridization

IHC: Immunohistochemistry
NGS: Next Generation Sequencing

GenPath® Oncology

GenPath® Women Health

GeneDx

Sequenom®

Baby Genes™

Kailos

ReproSource®

CircleGene

Ambry Genetics®

Genova Diagnostics®

Progenesis

LabCo Nous

dnaPower

Cynvenio

Tel:(81) 1107 0505